MEDIA ADVISORY: President Clinton to Open Town Hall on Prescription Drug Abuse at Johns Hopkins University
Town Hall to focus on solutions to the prescription drug abuse epidemic; Today Show correspondent Dr. Gail Saltz to moderate a panel discussion with United States Senator Amy Klobuchar, FDA Commissioner Margaret Hamburg, Former Congressman Patrick Kennedy and Johns Hopkins Behavioral Economist Dr. Douglas Hough
(Baltimore, MD) — On May 13, 2014, President Bill Clinton will open a town hall meeting co-hosted by the Clinton Health Matters Initiative (CHMI) and the Johns Hopkins Bloomberg School of Public Health to address prescription drug abuse. This date marks the one-year anniversary of President Clinton’s announcement of the Clinton Foundation's intent to address prescription drug misuse, through CHMI. This town hall will focus on the public health approach to scaling solutions to the prescription drug abuse epidemic.
WHAT: Town Hall on Prescription Drug Abuse
Prescription Drug Abuse: Evidence Informing Action
WHO: Opening Remarks: President Bill Clinton
Panel discussion:MODERATOR: Dr. Gail Saltz, Today Show correspondentU.S. Senator Amy KlobucharFDA Commissioner Dr. Margaret HamburgFormer Congressman Patrick KennedyJohns Hopkins Health Behavioral Economist Dr. Douglas Hough
Additional Remarks:Ronald Daniels, President, Johns Hopkins UniversityDr. Michael Klag, Dean, Johns Hopkins Bloomberg School of Public HealthDr. Andrea Gielen, Director, Johns Hopkins Center for Injury Research and PolicyDr. Caleb Alexander, Co-Director, Johns Hopkins Center for Drug Safety and Effectiveness
WHEN: Tuesday, May 13, 2014, 1:30 PM Media check-in begins: 12:30 PM
WHERE: Johns Hopkins Bloomberg School of Public Health Sommer Hall, 2nd Floor 615 North Wolfe Street Baltimore, MD 21205
Space is limited. Media registration is now open and press planning to cover must be credentialed by the Clinton Foundation. The deadline to apply is Monday, May 12 at 5 PM. To apply, please complete the form at: http://www.clintonfoundation.org/our-work/clinton-health-matters-initiative/press-rsvp
To watch the event online, please visit http://www.jhsph.edu/prescription-drug-abuse-town-hall
About the Clinton FoundationThe Bill, Hillary & Chelsea Clinton Foundation convenes businesses, governments, NGOs, and individuals to improve global health and wellness, increase opportunity for women and girls, reduce childhood obesity, create economic opportunity and growth, and help communities address the effects of climate change. Because of our work, 20,000 American schools are providing kids with healthy food choices in an effort to eradicate childhood obesity; 21,000 farmers in Malawi have improved their incomes by more than 500 percent; 248 million tons of greenhouse gas emissions are being reduced in cities worldwide; more than 5,000 people have been trained in marketable job skills in Colombia; 8.2 million people have access to lifesaving HIV/AIDS medications; $200 million in strategic investments have been made, impacting the health of 75 million people in the U.S.; and members of the Clinton Global Initiative have made nearly 2,800 Commitments to Action to improve more than 430 million lives around the world. Learn more at http://www.clintonfoundation.org, on Facebook, and on Twitter @ClintonFdn.
About the Johns Hopkins Bloomberg School of Public HealthFounded in 1916 as part of the Johns Hopkins University, the Bloomberg School of Public Health is the world's oldest and largest independent school of public health. Every day, the Bloomberg School works to keep millions safe from illness and injury by pioneering new research, deploying its knowledge and expertise in the field, and educating tomorrow's scientists and practitioners in the global defense of human life. The Center for Drug Safety and Effectiveness was established in 2012 at the Johns Hopkins Bloomberg School of Public Health to improve the safe and effective use of medications with a focus on prescription drug abuse. The knowledge base of the Center’s faculty reflects a diversity of fields, ranging from pharmacovigilance to regulatory policy. The Johns Hopkins Center for Injury Research and Policy is working to reduce opioid poisoning by better understanding the epidemiology of the problem, public opinion and practices related to the use of prescription pain medications, and policies and programs that reduce risk and promote the safe use of these drugs. Learn more at http://www.jhsph.edu, on Facebook and on Twitter @JohnsHopkinsSPH.